The price is where it is because the TT-034 failure dropped it through the floor and a consistent lack of progress has kept it there. Not because of people pointing that fact out
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025